Altido Therapeutics
PrivateLast Round
Seed
Jan 1, 2026
Total Funding Raised
$12.5M
Company Overview
Altido Therapeutics is a biotechnology company that develops cell-based immunotherapies, specifically CAR-TEAM therapies, to treat difficult-to-treat solid tumors like glioblastoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altido Therapeutics Comparables
Compare Altido Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlioCART GmbH | 88% | |
| Adaptin Bio | 84% | |
| Imvax | 83% |
Altido Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 1, 2026 |
Altido Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Seed |
| Mass General Brigham Innovation | Seed |
Altido Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Altido Therapeutics's valuation, stock price, and market status.
Is Altido Therapeutics a public or private company?
Altido Therapeutics is a private company.
What is the current stock price of Altido Therapeutics?
Altido Therapeutics is a private company with no public stock price. Caplight tracks Altido Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Altido Therapeutics worth (valuation)?
Valuation information for Altido Therapeutics is not publicly available.
Can I buy Altido Therapeutics stock?
Altido Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Altido Therapeutics's last funding round?
Altido Therapeutics's most recent funding round was Seed on January 1, 2026.
Who are the main investors in Altido Therapeutics?
Key investors in Altido Therapeutics include ARCH Venture Partners.
Will Altido Therapeutics IPO soon?
No public IPO plans have been announced for Altido Therapeutics.
How can I track Altido Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Altido Therapeutics's secondary market activity and sign up for updates.